Chinese Herbal Formula for COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate a 21-herb formula named modified Qing Fei Pai Du Tang (mQFPD) to treat COVID-19-positive outpatients with mild-to-moderate symptoms assigned to self-quarantined and home management. This the study aims to establish the safety and feasibility of the use of mQFPD vs placebo in 66 total subjects. Subsequent trials will evaluate other therapeutics as well as the efficacy of mQFPD in a larger study population.
Epistemonikos ID: 8824ca0e0d8e65c36cf0759255afdfd888e4b090
First added on: Jun 26, 2021